4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 4
Accession 0001104659-24-101030
CIK 0001953926other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:16 PM ET
Size
15.7 KB
Accession
0001104659-24-101030
Insider Transaction Report
Form 4
Transactions
- Conversion
Series C Convertible Preferred Stock
2024-09-16−1,742,858→ 0 total→ Common Stock (200,718 underlying) - Conversion
Common Stock
2024-09-16+180,635→ 180,635 total - Conversion
Common Stock
2024-09-16+200,718→ 801,624 total - Conversion
Common Stock
2024-09-16+420,271→ 600,906 total - Conversion
Series A Convertible Preferred Stock
2024-09-16−1,568,480→ 0 total→ Common Stock (180,635 underlying) - Conversion
Series B Convertible Preferred Stock
2024-09-16−3,649,263→ 0 total→ Common Stock (420,271 underlying)
Footnotes (3)
- [F1]On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F2]On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F3]On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001787092
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:16 PM ET
- Size
- 15.7 KB